Green Thumb Industries (GTBIF) Amortization of Deferred Charges (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Amortization of Deferred Charges came in at $13.4 million in Q1 2026, up 5.33% YoY from $12.8 million in Q1 2025, and up 8305.0% on a QoQ basis from $160000.0 in Q4 2025.
Green Thumb Industries (GTBIF) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Amortization of Deferred Charges data on file, last reported at $13.4 million in Q1 2026.
- Quarterly Amortization of Deferred Charges rose 5.33% year-over-year to $13.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 90.4% YoY) and the FY2025 annual result came in at $639000.0, down 79.21% from the prior year.
- Amortization of Deferred Charges advanced to $13.4 million in Q1 2026, from $160000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $31.2 million in Q3 2023 to a low of -$25.1 million in Q3 2025.
- A 5-year average of $4.4 million and a median of $2.4 million in 2023 frame the typical range for Amortization of Deferred Charges.
- The widest YoY moves for Amortization of Deferred Charges: up 1148.72% in 2022, down 177.93% in 2022.
- Tracing GTBIF's Amortization of Deferred Charges over 5 years: stood at -$22.7 million in 2022, then soared by 153.82% to $12.2 million in 2023, then slumped by 98.69% to $160000.0 in 2024, then changed by 0.0% to $160000.0 in 2025, then jumped by 8305.0% to $13.4 million in 2026.
- The last three Amortization of Deferred Charges figures came in at $13.4 million (Q1 2026), $160000.0 (Q4 2025), and -$25.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.71 Mn |
| Jun 30, 2026 | 13.71 Mn |
| Mar 31, 2026 | 13.45 Mn |
| Mar 31, 2026 | 13.45 Mn |
| Dec 31, 2025 | 160,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Sep 30, 2025 | -25.09 Mn |
| Sep 30, 2025 | -25.09 Mn |
| Jun 30, 2025 | 12.80 Mn |
| Jun 30, 2025 | 12.80 Mn |
| Mar 31, 2025 | 12.77 Mn |
| Mar 31, 2025 | 12.77 Mn |
| Dec 31, 2024 | 160,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | -21.76 Mn |
| Sep 30, 2024 | -21.76 Mn |
| Jun 30, 2024 | 22.58 Mn |
| Jun 30, 2024 | 22.58 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Mar 31, 2024 | 2.10 Mn |